Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study

Author:

Mukhtar Fahad,Boffetta Paolo,Dabo Bashir,Park Jong Y.,Tran Chi T. D.,Tran Thuan V.,Tran Huong Thi-Thanh,Whitney Madison,Risch Harvey A.,Le Linh C.,Zheng Wei,Shu Xiao-Ou,Luu Hung N.ORCID

Funder

National Cancer Institute

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma;W Wei;Hematol Amst Neth,2017

2. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium;A ‘t Mannetje;Environ Health Perspect,2016

3. National Cancer Institute. Overview of the SEER Program [Internet]. National Cancer Institute; 2018. Available: http://seer.cancer.gov/about/

4. Cancer treatment disparities in HIV-infected individuals in the United States;G Suneja;J Clin Oncol,2014

5. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area;AD Castel;AIDS Care,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3